白细胞介素-11驱动人类和小鼠酒精相关肝病
该研究探讨了白细胞介素-11(IL-11)在酒精性肝炎(AH)和各种病因肝硬化患者中的血清水平及预后价值,并在体外原代人类肝细胞和乙醇喂养野生型小鼠中验证。结果显示IL-11血清浓度和肝脏表达随肝病严重程度增加,血清水平高于6.4 pg/mL是代偿性和失代偿性肝硬化患者无移植生存的终末期肝病模型独立危险因素;在小鼠中,抗IL11RA减少致病信号通路并保护肝脏免受乙醇诱导的炎症和损伤。结论认为肝细胞中致病性IL-11信号在酒精相关肝病发病机制中起关键作用,可作为无移植生存的独立预后因素,阻断IL-11信号可能是人类酒精相关肝病尤其是AH的治疗选择。
要点
- IL-11血清浓度和肝脏表达随肝病严重程度增加,在酒精性肝炎中最明显。
- 血清IL-11水平高于6.4 pg/mL是肝硬化患者无移植生存的独立危险因素。
- 抗IL11RA减少致病信号通路并保护小鼠肝脏免受乙醇诱导的炎症和损伤。
核心结论
- 肝细胞中致病性IL-11信号在酒精相关肝病发病机制中起关键作用,并可能作为无移植生存的独立预后因素。
- 阻断IL-11信号可能是人类酒精相关肝病尤其是酒精性肝炎的治疗选择。
研究设计与样本
- 研究队列包括50例酒精性肝炎患者、110例肝硬化患者和19名健康志愿者,并在独立患者队列(n=186)中重复验证。
- 体外研究原代人类肝细胞暴露于乙醇;体内研究使用乙醇喂养的野生型小鼠,给予中和性鼠IL-11受体抗体(抗IL11RA)治疗,并检查酒精相关肝病的严重程度体征和标志物。
主要发现
- IL-11血清浓度和肝脏表达随肝病严重程度增加,在酒精性肝炎中最明显。
- 在多变量Cox回归中,血清水平高于6.4 pg/mL是代偿性和失代偿性肝硬化患者无移植生存的终末期肝病模型独立危险因素。
- 在小鼠中,酒精诱导的肝脏炎症严重程度与肝脏IL-11和IL11RA表达增强相关。
- 体外和体内,抗IL11RA减少致病信号通路(细胞外信号调节激酶、c-Jun N末端激酶、NADPH氧化酶4),并保护肝细胞和小鼠肝脏免受乙醇诱导的炎症和损伤。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Alcoholic hepatitis (AH) reflects acute exacerbation of alcoholic liver disease (ALD) and is a growing healthcare burden worldwide. Interleukin-11 (IL-11) is a profibrotic, proinflammatory cytokine with increasingly recognised toxicities in parenchymal and epithelial cells. We explored IL-11 serum levels and their prognostic value in patients suffering from AH and cirrhosis of various aetiology and experimental ALD. DESIGN: IL-11 serum concentration and tissue expression was determined in a cohort comprising 50 patients with AH, 110 patients with cirrhosis and 19 healthy volunteers. Findings were replicated in an independent patient cohort (n=186). Primary human hepatocytes exposed to ethanol were studied in vitro. Ethanol-fed wildtype mice were treated with a neutralising murine IL-11 receptor-antibody (anti-IL11RA) and examined for severity signs and markers of ALD. RESULTS: IL-11 serum concentration and hepatic expression increased with severity of liver disease, mostly pronounced in AH. In a multivariate Cox-regression, a serum level above 6.4 pg/mL was a model of end-stage liver disease independent risk factor for transplant-free survival in patients with compensated and decompensated cirrhosis. In mice, severity of alcohol-induced liver inflammation correlated with enhanced hepatic IL-11 and IL11RA expression. In vitro and in vivo, anti-IL11RA reduced pathogenic signalling pathways (extracellular signal-regulated kinases, c-Jun N-terminal kinase, NADPH oxidase 4) and protected hepatocytes and murine livers from ethanol-induced inflammation and injury. CONCLUSION: Pathogenic IL-11 signalling in hepatocytes plays a crucial role in the pathogenesis of ALD and could serve as an independent prognostic factor for transplant-free survival. Blocking IL-11 signalling might be a therapeutic option in human ALD, particularly AH.
引用
- Effenberger M, Widjaja AA, Grabherr F, et al. Interleukin-11 drives human and mouse alcohol-related liver disease. Gut. 2022. PMID: 35365572. doi:10.1136/gutjnl-2021-326076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。